Device Trial Radar · NCT06687590
Serranator POINT FORCE Registry
Last checked: Nov 20, 2026Latest source record: May 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jan 22, 2025
Primary completion
Jun 30, 2026
Study completion Aug 31, 2026
Sponsor
- Lead sponsor
- Cagent Vascular LLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Yale Cardiovascular Research Group; Julius Clinical
- First posted
- Nov 13, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario. The data and conclusions derived from this study will be used to provide clinical evidence for the clinical evaluation process.
Conditions
- Peripheral Artery Disease (PAD)
- Dysfunctional AV Fistula
- Dysfunctional AV Graft
Interventions
Peripheral balloon angioplastyDevice
Serration balloon angioplasty of iliac, femoral, iliofemoral, popliteal, infrapopliteal and pedal arteries, or dysfunctional native or synthetic arteriovenous dialysis fistula
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance EndpointTime frame: Peri-procedural
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
HonorHealth
Scottsdale, Arizona · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Hartford HealthCare
Hartford, Connecticut · Recruiting
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.